Gross Margin

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.

The LA Rams and energy firm CRC mark one year of a partnership to offset team emissions, but does this innovative, local-first model truly change the game?

After 30 years, CEO Jim Foster will retire, passing the torch to COO Birgit Girshick in a move that signals continuity and a new era of governance.

The medtech firm's preliminary results show a Q4 revenue uptick but miss yearly estimates, signaling a stabilizing but cautious path forward for 2026.

A major customer delay impacts Ceragon's Q4 revenue, but the company projects significant growth in 2026, banking on a strong backlog and new markets.

CMS withdraws a controversial rule, ensuring patient access to advanced wound care, but a new payment model still looms over the MedTech industry.

As legacy brand Hamilton Beach heads to a major conference, its high-stakes pivot from kitchen gadgets to health tech will be under the microscope.

Jasmine Alarcon’s promotion to oversee Southwest Marines housing comes as the privatized military housing sector faces intense pressure for reform.

Peachtree Group's new division closes nearly $30M in its first quarter, capitalizing on a growing credit gap in middle-market equipment finance.

The 2026 auto show reveals a market in flux. Hybrids are back, EVs adapt post-rebate, and the hunt for affordable cars intensifies. What's next?

Backed by Frazier Healthcare Partners, the new CareTria aims to slash patient wait times for medication with a powerful, end-to-end technology platform.

A new global study shows consumers embrace AI for product research but don't trust it for purchases, revealing a 'Confidence Economy' ruled by transparency.

A new tri-specific antibody, IM1240, safely hits cancer cells at massive doses in preclinical studies, potentially solving a key toxicity problem in immunotherapy.

NRG Energy names insider Robert J. Gaudette as its next CEO, signaling strategic continuity as the energy giant navigates a market in transformation.

The healthcare virtual assistant market is set to explode, promising radical efficiency but raising critical questions about privacy, bias, and patient trust.

Earable Neuroscience partners with Tonino Lamborghini for a $1,999 brainband and joins the NSF's network, betting big on the new market of luxury cognitive tech.

A routine prenatal screen can now detect a virus that causes birth defects, offering a path to prevention and sparking calls to change medical guidelines.

As COO/CFO Ashim Gupta prepares for a key investor conference, UiPath aims to prove its 'agentic automation' strategy can deliver sustained growth.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?